“Development of an 11-gene scoring system, Stem11, for AML patient outcome prediction using single-cell RNA sequencing in preleukemic mouse models”

https://pubmed.ncbi.nlm.nih.gov/38116120

This study used single-cell RNA sequencing to analyze preleukemic mouse models and developed an 11-gene scoring system, called Stem11, that predicts AML patient outcomes based on preleukemic transcriptional signatures.